81 related articles for article (PubMed ID: 27792966)
1. A genetic variant in miRNA binding site of glutamate receptor 4, metabotropic (GRM4) is associated with increased risk of major depressive disorder.
Dadkhah T; Rahimi-Aliabadi S; Jamshidi J; Ghaedi H; Taghavi S; Shokraeian P; Akhavan-Niaki H; Tafakhori A; Ohadi M; Darvish H
J Affect Disord; 2017 Jan; 208():218-222. PubMed ID: 27792966
[TBL] [Abstract][Full Text] [Related]
2. MiR-335 is involved in major depression disorder and antidepressant treatment through targeting GRM4.
Li J; Meng H; Cao W; Qiu T
Neurosci Lett; 2015 Oct; 606():167-72. PubMed ID: 26314506
[TBL] [Abstract][Full Text] [Related]
3. Association of GRM4 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma in Guangxi Chinese population.
Wang K; Zhao J; He M; Fowdur M; Jiang T; Luo S
Tumour Biol; 2016 Jan; 37(1):1105-12. PubMed ID: 26276359
[TBL] [Abstract][Full Text] [Related]
4. Association study of polymorphisms in the group III metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia.
Shibata H; Tani A; Chikuhara T; Kikuta R; Sakai M; Ninomiya H; Tashiro N; Iwata N; Ozaki N; Fukumaki Y
Psychiatry Res; 2009 May; 167(1-2):88-96. PubMed ID: 19351574
[TBL] [Abstract][Full Text] [Related]
5. Glutamate receptor metabotropic 7 (GRM7) gene polymorphisms in mood disorders and attention deficit hyperactive disorder.
Noroozi R; Taheri M; Omrani MD; Ghafouri-Fard S
Neurochem Int; 2019 Oct; 129():104483. PubMed ID: 31170425
[TBL] [Abstract][Full Text] [Related]
6. Role of GRM4 in idiopathic generalized epilepsies analysed by genetic association and sequence analysis.
Muhle H; von Spiczak S; Gaus V; Kara S; Helbig I; Hampe J; Franke A; Weber Y; Lerche H; Kleefuss-Lie AA; Elger CE; Schreiber S; Stephani U; Sander T
Epilepsy Res; 2010 May; 89(2-3):319-26. PubMed ID: 20338729
[TBL] [Abstract][Full Text] [Related]
7. Estrogen Receptor 1 Gene rs22346939 and rs9340799 Variants are Associated with Major Depressive Disorder and its Clinical Features.
Ozsoy F; Nursal AF; Karakus N; Demir MO; Yigit S
Curr Neurovasc Res; 2021; 18(1):12-19. PubMed ID: 34060989
[TBL] [Abstract][Full Text] [Related]
8. TPH2 -703G/T SNP may have important effect on susceptibility to suicidal behavior in major depression.
Yoon HK; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):403-9. PubMed ID: 19162119
[TBL] [Abstract][Full Text] [Related]
9. miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment.
Lopez JP; Lim R; Cruceanu C; Crapper L; Fasano C; Labonte B; Maussion G; Yang JP; Yerko V; Vigneault E; El Mestikawy S; Mechawar N; Pavlidis P; Turecki G
Nat Med; 2014 Jul; 20(7):764-8. PubMed ID: 24908571
[TBL] [Abstract][Full Text] [Related]
10. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
Okumura T; Kishi T; Okochi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Tsunoka T; Inada T; Ozaki N; Iwata N
Neuropsychobiology; 2010; 61(2):57-63. PubMed ID: 20016223
[TBL] [Abstract][Full Text] [Related]
11. Association between the group III metabotropic glutamate receptor gene polymorphisms and attention-deficit/hyperactivity disorder and functional exploration of risk loci.
Zhang Q; Chen X; Li S; Yao T; Wu J
J Psychiatr Res; 2021 Jan; 132():65-71. PubMed ID: 33068816
[TBL] [Abstract][Full Text] [Related]
12. Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population.
Tsunoka T; Kishi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Okumura T; Inada T; Ozaki N; Iwata N
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):875-9. PubMed ID: 19386277
[TBL] [Abstract][Full Text] [Related]
13. Association of EGF, IGFBP-3 and TP53 Gene Polymorphisms with Major Depressive Disorder in Slovak Population.
Mahmood S; Evinová A; Škereňová M; Ondrejka I; Lehotský J
Cent Eur J Public Health; 2016 Sep; 24(3):223-230. PubMed ID: 27755861
[TBL] [Abstract][Full Text] [Related]
14. Resequencing three candidate genes for major depressive disorder in a Dutch cohort.
Verbeek EC; Bevova MR; Bochdanovits Z; Rizzu P; Bakker IM; Uithuisje T; De Geus EJ; Smit JH; Penninx BW; Boomsma DI; Hoogendijk WJ; Heutink P
PLoS One; 2013; 8(11):e79921. PubMed ID: 24278217
[TBL] [Abstract][Full Text] [Related]
15. Association between major depressive disorder and the -1438A/G polymorphism of the serotonin 2A receptor gene.
Choi MJ; Lee HJ; Lee HJ; Ham BJ; Cha JH; Ryu SH; Lee MS
Neuropsychobiology; 2004; 49(1):38-41. PubMed ID: 14730199
[TBL] [Abstract][Full Text] [Related]
16. No relationship found between -1438A/G polymorphism of the serotonin 2A receptor gene (rs6311) and major depression susceptibility in a northeastern Thai population.
Tencomnao T; Thongrakard V; Phuchana W; Sritharathikhun T; Suttirat S
Genet Mol Res; 2010 Jun; 9(2):1171-6. PubMed ID: 20589614
[TBL] [Abstract][Full Text] [Related]
17. Association of C/T polymorphism in intron 14 of the dopamine transporter gene (rs40184) with major depression in a northeastern Thai population.
Pattarachotanant N; Sritharathikhun T; Suttirat S; Tencomnao T
Genet Mol Res; 2010 Mar; 9(1):565-72. PubMed ID: 20391341
[TBL] [Abstract][Full Text] [Related]
18. Vesicular monoamine transporter 1 gene polymorphism and white matter integrity in major depressive disorder.
Won E; Han KM; Kang J; Kim A; Yoon HK; Chang HS; Park JY; Lee MS; Greenberg T; Tae WS; Ham BJ
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jul; 77():138-145. PubMed ID: 28408293
[TBL] [Abstract][Full Text] [Related]
19. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
20. Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer.
Bagheri F; Mesrian Tanha H; Mojtabavi Naeini M; Ghaedi K; Azadeh M
Mol Med Rep; 2016 May; 13(5):4494-8. PubMed ID: 27035115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
